D. M. Opris, P. Franke, A. D. Schlüter
FULL PAPER
= 0.07 (ethyl acetate/hexane, 1:3). H NMR (CDCl3, 500 MHz): δ
8.00 (dd, 3J = 8 Hz, 4 H, pyridyl-H), 8.52 (d, 4 H, 3J = 8 Hz,
1
= 0.89 (t, 12 H, CH3), 1.29 (mc, 24 H, β-, γ-, δ-CH2), 1.63 (mc, 8 pyridyl-H), 8.88 (s, 4 H, pyridyl-H) ppm. 13C NMR (CDCl3,
H, β-CH2), 3.1 (s, 2 H, acetylene-H), 3.50 (m, 8 H, α-CH2), 4.46 126 MHz): δ = 14.05, 19.42, 22.65, 25.49, 25.92, 28.73, 30.61, 31.72,
(s, 4 H, benzyl-H), 4.59 (s, 4 H, benzyl-H), 7.42 (s, 2 H, phenyl-H),
62.29, 68.24, 70.93, 71.04, 71.99, 72.20, 89.35, 89.56, 98.15, 121.56,
7.52 (s, 2 H, phenyl-H), 7.57 (s, 2 H, phenyl-H) 7.59 (s, 2 H, phenyl- 123.45, 124.07, 125.51, 129.15, 130.14, 134.35, 135.32, 135.43,
3
H) 7.62 (s, 2 H, phenyl-H) 7.72 (s, 2 H, phenyl-H), 8.04 (d, J =
136.96, 139.51, 139.77, 140.18, 146.69, 153.36 ppm. MS (FAB):
m/z (%) = 1546 (19.72), 1462 (6.81). C105H116N4O7 (1546.07): calcd.
C 81.57, H 7.56, N 3.62; found C 81.18, H 7.42, N 3.76.
3
9 Hz, 2 H, pyridyl-H), 8.55 (d, J = 9 Hz, 2 H, pyridyl-H), 8.95 (s,
2 H, pyridyl-H) ppm. 13C NMR (CDCl3, 126 MHz): δ = 14.04,
22.62, 25.85, 25.90, 29.69, 31.68, 70.89, 70.99, 71.85, 72.24, 88.97,
121.07, 122.59, 123.57, 123.95, 126.24, 129.28, 130.32, 130.92,
134.16, 135.29, 135.71, 138.1, 139.64, 140.25, 147.70, 153.57,
154.99 ppm. MS (FAB): m/z (%) = 1014 (100), 926 (57.53).
C70H80N2O4 (1013.40): calcd. C 82.96, H 7.96, N 2.76 found C
81.21, H 7.59, N 2.53.
5,5Ј-Bis{3-hexyloxymethyl-5-[(3-iodophenyl)ethynyl]phenyl}-2,2Ј-
bipyridyl (18c): 18b (2.00 g, 3.42 mmol), 1,3-diiodobenzene (23 g,
70 mmol), toluene (230 mL), triethylamine (230 mL), [Pd(PPh3)4]
(0.04 equiv.) and CuI (0.04 equiv.), 3 d. The solvent was removed
and the crude product purified by column chromatography through
silica gel (hexane/ethyl acetate, 6:1) to give 2.00 g of 18c (60%) as
white solid. Rf (hexane/ethyl acetate, 6:1) = 0.17. 1H NMR (CDCl3,
250 MHz): δ = 0.91 (t, 6 H, CH3), 1.23–1.42 (m, 12 H, γ-, δ-, ε-
CH2), 1.65 (m, 4 H, β-CH2), 3.53 (t, 4 H, α-CH2), 4.56 (s, 4 H,
benzyl-H), 7.06 (t, 2 H, phenyl-H), 7.42 (d, 2 H, phenyl-H), 7.45
(s, 2 H, phenyl-H), 7.53 (s, 2 H, phenyl-H), 7.59 (d, 2 H, phenyl-
5Ј-{3-[3-Ethynyl-5-(hexyloxymethyl)phenylethynyl]-5-(hexyloxy-
methyl)phenyl}-5-{3-[3-ethynyl-5-(hexyloxymethyl)phenylethynyl]-5-
(tetrahydropyran-2-yloxymethyl)phenyl}-2,2Ј-bipyridinyl (17): 15
(2.90 g, 2.19 mmol), ammonium fluoride trihydrate (1.45 g,
4.52 mmol). The compound was purified by column chromatogra-
phy through silica gel (hexane/ethyl acetate, 1:3) to give 2.15 g 17
(97%) as a white solid. Rf (ethyl acetate/hexane, 1:3) = 0.36. 1H
3
H), 7.64 (s, 2 H, phenyl-H), 7.83 (s, 2 H, phenyl-H), 7.96 (dd, J =
4
3
8, J = 2 Hz, 2 H, pyridyl-H), 8.54 (d, J = 8 Hz, 2 H, pyridyl-H),
NMR (CDCl3, 500 MHz): δ = 0.86 (t, 9 H, CH3), 1.18–1.38 (mc, 8.94 (d, 4J = 2 Hz, 2 H, pyridyl-H) ppm. 13C NMR (CDCl3,
18 H, γ-, δ-, ε-CH2), 1.50–2.00 (mc, 12 H, β-CH2, THP), 3.09 (s, 2 63 MHz): δ = 14.00, 22.58, 25.84, 29.68, 31.64, 70.95, 72.13, 88.18,
H, acetylene-H), 3.35–3.57 (m, 7 H, α-CH2, THP), 3.91 (m, 1 H, 90.26, 93.67, 121.01, 123.70, 125.07, 126.22, 129.16, 129.81, 130.22,
THP), 4.39 (s, 4 H, benzyl-H), 4.47 (s, 2 H, benzyl-H), 4.51 (d, J
= 12 Hz, 1 H, benzyl-H), 4.71 (t, 1 H, THP), 4.82 (d, J = 12 Hz,
1 H, benzyl-H), 7.36 (s, 2 H, phenyl-H), 7.45 (s, 2 H, phenyl-H),
7.5 (s, 2 H, phenyl-H) 7.55 (s, 4 H, phenyl-H) 7.65 (s, 2 H, phenyl-
H) 7.94 (d, 3J = 8 Hz, 2 H, pyridyl-H), 8.48 (d, 3J = 8 Hz, 2 H,
pyridyl-H), 8.86 (s, 2 H, pyridyl-H) ppm. 13C NMR (CDCl3,
126 MHz): δ = 13.87, 19.17, 22.45, 25.29, 25.74, 29.51, 30.37, 31.49,
61.93, 67.98, 70.66, 71.56, 71.50, 77.81, 82.63, 88.86, 89.52, 97.85,
120.81, 122.42, 123.25, 123.70, 123.73, 125.82, 126.05, 128.93,
130.00, 130.18, 130.58, 130.68, 131.03, 133.89, 134.86, 135.21,
137.73, 139.47, 139.67, 140.07, 147.34, 154.63 ppm. MS (FAB):
m/z (%) = 1013 (12.30), 927 (6.35). C69H76N2O5 (1013.35): calcd.
C 81.78, H 7.56, N 2.76; found C 81.22, H 7.34, N 2.38.
2
130.69, 135.16, 135.51, 137.38, 138.00, 140.17, 140.21, 147.59,
154.88 ppm. MS (EI, 80 eV): m/z (%) = 988.9 (57.17), 988.0 (96.83),
888.9 (43.63), 887.9 (100), 761.9 (26.69), 127.9 (45.09), 42.0 (49.08).
HRMS: (C52H50I2N2O2): calcd. 988.19617; found 988.19436.
2
Macrocycle E5: 18c (1.9 g, 1.92 mmol), 18b (1.12 g, 1.92 mmol), tri-
ethylamine (600 mL), toluene (800 mL), [Pd(PPh3)4] (0.04 equiv.),
copper iodide (0.04 equiv.), gave 540 mg of cycle E5 (28%).
2-(5-{3-Bromo-5-[(hexyloxy)methyl]phenyl}pyridin-2-yl)-5-{3-[(hexyl-
oxy)methyl]-5-(trimethylsilyl)phenyl}pyridine (19a): To
a stirred
solution of 4a (3.03 g, 7.09 mmol) in dry toluene (50 mL) a 1.6 n
solution of BuLi in hexane (4.7 mL, 7.52 mmol) was added drop-
wise at –78 °C. To the resulting red solution Me3SnCl (1.53 g,
7.68 mmol) was added in solid form after 2 h. The mixture was let
to warm to room temp. (overnight). Compound 13 (2.98 g,
7.09 mmol) was then added to the brownish solution of 5a. The
mixture was degassed and [Pd(PPh3)4] (3 mol%) added. The reac-
tion mixture was degassed once more and refluxed for 5 d. Then it
was cooled to room temp. and an aq. satd. KF solution (90 mL)
added followed by an aq. 2 n Na2CO3 solution (150 mL). The
phases were separated, the aqueous one was extracted with toluene
(2×100 mL) and the combined organic phases washed with water
(100 mL) and dried (MgSO4). The solvent was removed and the
crude brown oil purified by column chromatography through silica
gel (hexane/ethyl acetate, 9:1) to give 2.18 g of 19a (44%) as a white
solid, together with the homocoupling products 6 (0.64 g) and 11
Macrocycle E4: (X1 = X2 = Hex, X3 = CH2OHex, Scheme 1). 16
(300 mg, 0.30 mmol), 12 (236 mg, 0.30 mmol), triethylamine
(100 mL), toluene (100 mL), [Pd(PPh3)4] (0.04 equiv.), and CuI
(0.04 equiv.), gave 83 mg of cycle E4 (19%). 1H NMR (CDCl3,
250 MHz): δ = 0.91 (t, 18 H, CH3), 1.20–1.49 (mc, 36 H, γ-, δ-, ε-
CH2), 1.67 (mc, 12 H, β-CH2), 3.53 (m, 12 H, α-CH2), 4.51 (s, 4
H, benzyl-H), 4.59 (s, 8 H, benzyl-H), 7.5 (s, 4 H, phenyl-H), 7.55
(s, 4 H, phenyl-H), 7.62 (s, 4 H, phenyl-H) 7.75 (s, 6 H, phenyl-H),
8.06 (dd, J = 8, J = 2 Hz, 4 H, pyridyl-H), 8.53 (d, J = 8 Hz, 4
H, pyridyl-H), 8.96 (s, 4 H, pyridyl-H) ppm. 13C NMR (CDCl3,
126 MHz): δ = 14.03, 22.63, 23.91, 25.89, 29.14, 29.74, 31.70, 70.90,
70.98, 71.99, 72.27, 89.23, 89.70, 121.11, 123.55, 124.04, 125.91,
129.55, 129.99, 130.16, 134.48, 135.12, 135.40, 137.92, 139.65,
140.25, 147.59, 154.96 ppm. MS (FAB): m/z (%) = 1546 (100), 1460
(57.85). C106H120N4O6 (1546.11): calcd. C 82.34, H 7.82, N 3.62;
found C 81.27, H 7.54, N 3.50.
3
4
3
1
(0.43 g). H NMR (CDCl3, 270 MHz): δ = 0.43 [s, 9 H, Si(CH3)3],
0.75–0.95 (m, 6 H, CH3), 1.20–1.40 (m, 12 H, γ-, δ-, ε-CH2), 1.60–
1.75 (m, 4 H, β-CH2), 3.45–3.55 (m, 4 H, α-CH2), 4.53 (s, 2 H,
benzyl-H), 4.59 (s, 2 H, benzyl-H), 7.53 (s, 3 H, phenyl-H), 7.61 (s,
Macrocycle E1 (20): (X1 = THP, X2 = Hex, X3 = CH2OHex, 1 H, phenyl-H), 7.68 (s, 2 H, phenyl-H), 7.98 (dd, 3J = 8, 4J =
Scheme 1). 17 (1.84 g, 1.82 mmol), 12 (1.44 g, 1.82 mmol), triethyl-
amine (600 mL), toluene (600 mL), [Pd(PPh3)4] (80 mg, 0.04
equiv.), CuI (13 mg, 0.04 equiv.), gave 0.66 g of cycle 20 (23%). 1H
2 Hz, 1 H, pyridyl-H), 8.03 (dd, 3J = 8, 4J = 2 Hz, 1 H, pyridyl-
H), 8.52 (d, 3J = 8 Hz, 2 H, pyridyl-H), 8.93 (s, 1 H, pyridyl-H),
8.93 (s, 1 H, pyridyl-H) ppm. 13C NMR (CDCl3, 63 MHz): δ =
NMR (CDCl3, 250 MHz): δ= 0.88 (t, 15 H, CH3), 1.20–1.44 (mc, –1.24, 13.60, 13.88, 22.22, 22.45, 25.71, 25.78, 29.52, 29.60, 31.27,
30 H, γ-, δ-, ε-CH2), 1.50–2.00 (mc, 16 H, THP, β-CH2), 3.40–3.64 31.52, 31.79, 33.65, 70.62, 70.80, 71.62, 72.62, 120.72, 120.81,
(m, 11 H, THP, α-CH2), 3.92 (m, 1 H, THP), 4.46 (s, 4 H, benzyl-
123.04, 124.25, 126.65, 128.67, 129.69, 130.89, 132.15, 134.59,
H), 4.52 (s, 7 H, THP, benzyl-H), 4.76 (t, 1 H, THP), 5.84 (d, 1 H, 134.86, 135.00, 136.63, 136.81, 138.74, 139.43, 141.49, 141.82,
benzyl-H), 7.36–7.60 (m, 12 H, phenyl-H), 7.68 (s, 6 H, phenyl-H), 147.30, 147.58, 154.09, 155.00 ppm. MS (EI): m/z (%) = 688 (100),
832
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 822–837